1 / 16

Fetal Haemolytic Disease

Fetal Haemolytic Disease. Maternal antibodies develop against fetal red blood cells IgG antibodies cross the placenta Haemolysis, anaemia, high-output cardiac failure & death. Usually a problem with subsequent pregnancies but may occur in the index pregnancy. Causes.

gabi
Télécharger la présentation

Fetal Haemolytic Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fetal Haemolytic Disease

  2. Maternal antibodies develop against fetal red blood cells IgG antibodies cross the placenta Haemolysis, anaemia, high-output cardiac failure & death

  3. Usually a problem with subsequent pregnancies but may occur in the index pregnancy

  4. Causes • ABO – does not usually cause significant haemolytic disease. • Anti-Kell – causes fetal bone marrow aplasia. • Rhesus – D antigen anti-D c antigen anti-c E antigen anti-E

  5. Incidence • Approx 17% of the population is Rh-ve 10% of women at risk of developing anti-D. Incidence 1/1000 pregnancies

  6. Predisposing Factors • Miscarriage and ectopic pregnancy • Invasive procedures • ECV • Abdominal trauma • Antepartum haemorrhage • Labour and birth

  7. Initial exposure Small IgM response Subsequent exposure Large IgG response

  8. IgG crosses placenta Forms antigen-antibody complex on red cell Red cells phagocytosed Anaemia and haemolysis

  9. Anaemia • Fetal hypoxia • Hepatic and cardiac dysfunction • Oedema, ascites, pericardial & pleural effusions - HYDROPS

  10. Haemolysis • Increased bilirubin • Jaundice postnatally • Kernicterus

  11. Prevention • Anti-D after any sensitizing episode after 12 weeks • Consider routine prophylaxis

  12. Management • Check antibodies at booking and 3rd trimester • If antibodies present – check antibody levels every 4 weeks to 28 weeks and then 2-weekly to term • <4IU/ml – severe disease rare • 4-15IU/ml – moderate risk • >15IU/ml – 50% risk of severe anaemia

  13. Check paternal genotype D antigen autosomal dominant Father DD – fetus Rh positive Father d/D – 50% chance that fetus will be Rh+ve

  14. Measurement of blood velocity in middle cerebral artery. • Hyperkinetic circulation correlates with fetal anaemia and need for further treatment.

  15. Anti-D for sensitising events after 12 weeks. • If anti-D antibodies present do not give more anti-D. • Serial measurements of Anti-D levels. • Observe for signs of fetalanemia – if anemic transfuse or deliver.

More Related